635 results on '"Lewis, Basil S."'
Search Results
2. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
3. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial
4. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
5. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
6. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
7. Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.
8. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
9. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
10. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
11. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
12. Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)
13. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
14. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento del síndrome coronario agudo (SCA) en pacientes sin elevación persistente del segmento ST
15. Guía ESC 2020 para el tratamiento de las cardiopatías congénitas del adulto
16. Automated Computer-Assisted Diagnosis of Obstructive Coronary Artery Disease in Emergency Department Patients Undergoing 256-Slice Coronary Computed Tomography Angiography for Acute Chest Pain
17. Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study
18. Low cardiorespiratory fitness and coronary artery calcification: Complementary cardiovascular risk predictors in asymptomatic type 2 diabetics
19. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial
20. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
21. Automatic Assessment of Coronary Artery Calcium Score from Contrast-Enhanced 256-Row Coronary Computed Tomography Angiography
22. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
23. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
24. Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial
25. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
26. Cardiac Computed Tomography Angiographic Findings as Predictors of Late Heart Failure in an Asymptomatic Diabetic Cohort: An 8-Year Prospective Follow-Up Study
27. Abstract 16714: Characterization of Types and Sizes of Myocardial Infarction Reduced With Evolocumab in FOURIER
28. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
29. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
30. Diagnostic Accuracy of 256-row Computed Tomographic Angiography for Detection of Obstructive Coronary Artery Disease Using Invasive Quantitative Coronary Angiography as Reference Standard
31. Absence of the α2c-Adrenoceptor Del322–325 Allele is Associated With Increased Mortality in Patients With Chronic Systolic Heart Failure
32. Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
33. Stenting of the unprotected left main coronary artery in patients with severe aortic stenosis prior to percutaneous valve interventions
34. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
35. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
36. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
37. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
38. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
39. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
40. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
41. Pulse pressure and coronary atherosclerosis in asymptomatic type 2 diabetes mellitus: A 64 channel cardiac computed tomography analysis
42. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
43. Changes in the initial slope of the QRS in ischemic patients and normal subjects undergoing scintigraphy withdipyridamole
44. Prognostic impact of abdominal fat distribution and cardiorespiratory fitness in asymptomatic type 2 diabetics
45. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
46. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES
47. Cardiac computed tomographic angiography for risk stratification and prediction of late cardiovascular outcome events in patients with a chest pain syndrome
48. Image quality in obese patients undergoing 256-row computed tomography coronary angiography
49. Long-term assessment of nocturnal Cheyne-Stokes respiration in patients with heart failure
50. “ECG variability contour” method reveals amplitude changes in both ischemic patients and normal subjects during Dipyridamole stress: a preliminary report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.